Advertisements

ASPIVIX and Bayer Switzerland Revolutionize Women’s Health Procedures

by Ella

In a groundbreaking collaboration, women’s health medtech company ASPIVIX has partnered with Bayer Switzerland to introduce Carevix, a revolutionary cervical stabilizer aimed at reducing pain and bleeding during transcervical procedures, particularly IUD placement. Leveraging Bayer’s extensive experience in contraceptive solutions and ASPIVIX’s innovative approach to gynecology, this collaboration aims to transform the gynecological experience for women worldwide.

Advertisements

Traditional methods involving the use of the century-old cervical tenaculum often result in discomfort and pain during IUD insertion, impacting millions of women globally. Carevix offers a game-changing solution, utilizing suction technology to stabilize the cervix effectively. Clinical trials have demonstrated the device’s efficacy in significantly reducing both pain and bleeding, addressing a crucial unmet need in women’s healthcare.

Advertisements

ASPIVIX CEO, Mathieu Horras, expressed enthusiasm about the partnership, highlighting the shared goal of empowering women to choose contraceptive solutions without fear of pain or bleeding. Backed by extensive research and clinical data, Carevix promises to enhance the experience of IUD adoption and placement, as well as other gynecological procedures, for millions of women worldwide.

Advertisements

Bayer Switzerland Women’s Healthcare lead, Marco Gierten, emphasized Bayer’s commitment to advancing solutions that offer significant benefits to patients. The collaboration underscores Bayer’s dedication to improving women’s health outcomes through innovative technologies and partnerships with industry leaders like ASPIVIX.

Advertisements

With CE Mark approval received in December 2023, ASPIVIX’s Carevix has been validated for its efficacy and safety in gynecological procedures. This milestone further solidifies the device’s position as a game-changer in women’s health, offering a promising solution to address the challenges associated with traditional cervical stabilization methods.

Through this partnership, ASPIVIX and Bayer Switzerland are poised to revolutionize women’s health procedures, providing women with access to safer, more comfortable, and effective options for gynecological care.

Advertisements
Advertisements

You May Also Like

Womenhealthdomain is a professional women's health portal website, the main columns include women's mental health, reproductive health, healthy diet, beauty, health status, knowledge and news.

【Contact us: [email protected]

[email protected]

Call: 18066312111

© 2023 Copyright Womenhealthdomain.com